Would you offer a bone marrow biopsy to the patient with normal CBC and low MDS-associated mutation burden found on NGS?

Generally speaking, we don't perform NGS sequencing for MDS-associated somatic mutations in individuals with normal blood counts. However, the issue does arise when cancer patients undergo blood-based sequencing for other reasons, for example. And, in the future, we may see more mutation testing in ...